18F-NOTA-NFB PET/MRI in glioma recurrence: comparison with 11C-methionine PET/MRI and contrast-enhanced MRI
Journal of Neuro-Oncology · 2025
DOI: 10.1007/s11060-025-05159-x ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Neuro-Oncology, 2025. Verfasst von Zhenwei Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Daping Hospital, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Glioma, Magnetic Resonance Imaging, Brain Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Science and Technology Innovation Ability Enhancement Project of Army Medical University, Chongqing Clinical Research Centre of Imaging and Nuclear Medicine, Natural Science Foundation of Chongqing.
Abstract (Originalsprache)
PURPOSE: To investigate the clinical utility of 18F-NOTA-NFB PET/MRI relative to 11C-methionine (11C-MET) PET/MRI and contrast-enhanced MRI (CE-MRI) for glioma recurrence detection. METHODS: Patients with suspected recurrence of glioma were prospectively enrolled. All patients underwent paired 18F-NOTA-NFB and 11C-MET PET/MRI. Diagnostic efficiency of glioma recurrence detection by different imaging methods were assessed and compared. The suspected lesions showed via 18F-NOTA-NFB and 11C-MET PET/MRI were compared by SUVmax and tumor-to-background ratio (TBR). The diagnostic performance of 18F-NOTA-NFB and 11C-MET SUVmax/TBR was tested by receiver operating characteristic curve. RESULTS: Thirty-eight patients with suspected recurrent glioma were included, with 28 positive for recurrent gliomas and 10 negative for recurrence which were confirmed by the pathology or clinical follow-up. For visual assessment, the accuracy and specificity of 18F-NOTA-NFB PET were equivalent to 11C-MET PET (accuracy: 92.11% vs. 94.74%, P = 1.00; specificity: 70.00% vs. 80.00%, P = 1.00) and higher than CE-MRI (accuracy: 92.11% vs. 76.32%, P = 0.031; specificity: 70.00% vs. 10.00%, P = 0.031). For quantitative analysis, in recurrent gliomas, 18F-NOTA-NFB PET revealed higher SUVmax (P = 0.007) and TBR (P = 0.002) than treatment-related effects, with higher TBR for recurrence than that of 11C-MET (P < 0.001). Although 11C-MET SUVmax had the highest AUC of 0.911 for detecting glioma recurrence, but with no significant difference relative to 11C-MET TBR (AUC = 0.889, P = 0.75), 18F-NOTA-NFB SUVmax (AUC = 0.793, P = 0.32), and 18F-NOTA-NFB TBR (AUC = 0.829, P = 0.42). CONCLUSION: The diagnostic efficacy of 18F-NOTA-NFB PET or PET/MRI performed equivalent to 11C-MET PET or PET/MRI, and better than CE-MRI for diagnosis of recurrent gliomas. Compared to 11C-MET, 18F-NOTA-NFB PET/MRI exhibited higher TBR, giving advantages in glioma delineation that might provide valuable information for making treatment strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Daping Hospital, Army Medical University, Chongqing, China.
- Department of Medical Engineering, Daping Hospital, Army Medical University, Chongqing, China.
- Department of Infectious Diseases, Southwest Hospital, Army Medical University, Chongqing, China.
- Department of Neurosurgery, Daping Hospital, Army Medical University, Chongqing, China. xuliu559@163.com.
- Department of Radiology, Daping Hospital, Army Medical University, Chongqing, China. wgzhang01@163.com.
- Chongqing Clinical Research Center for Imaging and Nuclear Medicine, Chongqing, China. wgzhang01@163.com.
Förderung
- Science and Technology Innovation Ability Enhancement Project of Army Medical University
- Chongqing Clinical Research Centre of Imaging and Nuclear Medicine
- Natural Science Foundation of Chongqing
- Chongqing Science and Health Joint Medical Research Project-Young and Middle-aged High-level Talent Project
- AI Medical Research Project of Army Medical Center
Zitieren
APA
Du, Z., Luo, Y., Sun, J., Long, H., You, J., Li, X., Xu, L., Zhang, W., & Chen, X. (2025). 18F-NOTA-NFB PET/MRI in glioma recurrence: comparison with 11C-methionine PET/MRI and contrast-enhanced MRI. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-025-05159-x
Vancouver
Du Z, Luo Y, Sun J, Long H, You J, Li X, et al. 18F-NOTA-NFB PET/MRI in glioma recurrence: comparison with 11C-methionine PET/MRI and contrast-enhanced MRI. Journal of Neuro-Oncology. 2025. doi:10.1007/s11060-025-05159-x
BibTeX
@article{Du2025,
author = {Du, Zhenwei and Luo, Yi and Sun, Jinju and Long, He and You, Jianping and Li, Xin and Xu, Lunshan and Zhang, Weiguo and Chen, Xiao},
title = {18F-NOTA-NFB PET/MRI in glioma recurrence: comparison with 11C-methionine PET/MRI and contrast-enhanced MRI},
journal = {Journal of Neuro-Oncology},
year = {2025},
doi = {10.1007/s11060-025-05159-x}
}
EUVIMED